RH Bophelo Ltd
Company Profile
Business description
RH Bophelo Ltd is a healthcare investment company. Its main business involves the acquisition of healthcare assets in commercial entities or special situations across the South African market. It is engaged in making equity, quasi-equity, and equity-related investments in healthcare and financial sectors, specifically in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company's operating segments are the Healthcare segment and the Financial Services segment. The majority of its revenue is generated from the Healthcare segment, which focuses on making investments in healthcare infrastructure, healthcare technology, and property companies.
Contact
1, Melrose Boulevard
Unit 12, 1st Floor, Melrose Arch
JohannesburgGT2191
ZAFT: +27 100072171
Sector
Financial Services
Stock type
Cyclical
Industry
Asset Management
Fiscal Year End
28 February 2026
Employees
742
Stocks News & Analysis
stocks
Navigating the ASX dividend landscape in 2026
stocks
Meta stock has struggled amid AI spending concerns. Is it a buy?
stocks
Netflix Earnings: Strong, as expected; 2026 guidance confirms decelerating growth
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,160.10 | 67.70 | 0.74% |
| CAC 40 | 8,069.17 | 6.59 | 0.08% |
| DAX 40 | 24,560.98 | 142.14 | -0.58% |
| Dow JONES (US) | 49,077.23 | 588.64 | 1.21% |
| FTSE 100 | 10,138.09 | 11.31 | 0.11% |
| HKSE | 26,585.06 | 97.55 | 0.37% |
| NASDAQ | 23,224.82 | 270.50 | 1.18% |
| Nikkei 225 | 52,774.64 | 216.46 | -0.41% |
| NZX 50 Index | 13,475.12 | 57.95 | 0.43% |
| S&P 500 | 6,875.62 | 78.76 | 1.16% |
| S&P/ASX 200 | 8,835.90 | 67.00 | 0.76% |
| SSE Composite Index | 4,116.94 | 3.29 | 0.08% |